Related references
Note: Only part of the references are listed.Antibiotics for the treatment of dysentery in children
Beatrix S. Traa et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2010)
Novel Nucleotide Human Immunodeficiency Virus Reverse Transcriptase Inhibitor GS-9148 with a Low Nephrotoxic Potential: Characterization of Renal Transport and Accumulation
Tomas Cihlar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Pharmacokinetics of Ceftriaxione, a Third-Generation Cephalosporin, in Pediatric Patients
Kyoko Fukumoto et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2009)
Renal Vulnerability to Drug Toxicity
Mark A. Perazella
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
The Carnitine Transporter SLC22A5 Is Not a General Drug Transporter, but It Efficiently Translocates Mildronate
Silke Grigat et al.
DRUG METABOLISM AND DISPOSITION (2009)
Carnitine/Organic Cation Transporter OCTN2 (Slc22a5) Is Responsible for Renal Secretion of Cephaloridine in Mice
Takashi Kano et al.
DRUG METABOLISM AND DISPOSITION (2009)
Functional Characterization of Multidrug and Toxin Extrusion Protein 1 as a Facilitative Transporter for Fluoroquinolones
Kin-ya Ohta et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Molecular evidence for an involvement of organic anion transporters (OATs) in aristolochic acid nephropathy
Nadiya Bakhiya et al.
TOXICOLOGY (2009)
Nephrolithiasis Caused by Ceftriaxone in a 3-Year-Old Child with Ureteropelvic Junction Obstruction
Vesna Stojanovic et al.
CASE REPORTS IN MEDICINE (2009)
Differentiation-dependent regulation of the intestinal folate uptake process: studies with Caco-2 cells and native mouse intestine
Veedamali S. Subramanian et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2008)
Protective effect of morin on the imipenem-induced nephrotoxicity in rabbits
Sung-Chul Lim et al.
ARCHIVES OF PHARMACAL RESEARCH (2008)
Physiological and pharmacokinetic roles of H+/organic cation antiporters (MATE/SLC47A)
Tomohiro Terada et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Involvement of multidrug resistance-associated protein 2 (Abcc2) in molecular weight-dependent biliary excretion of β-lactam antibiotics
Yukio Kato et al.
DRUG METABOLISM AND DISPOSITION (2008)
Safety of ceftriaxone sodium at extremes of age
Scott V. Monte et al.
EXPERT OPINION ON DRUG SAFETY (2008)
Drug-induced crystal nephropathy: an update
Sri G. Yarlagadda et al.
EXPERT OPINION ON DRUG SAFETY (2008)
Aristolochic acid nephropathy: A worldwide problem
Frederic D. Debelle et al.
KIDNEY INTERNATIONAL (2008)
Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation
A. A. Pozdzik et al.
KIDNEY INTERNATIONAL (2008)
The proton-coupled folate transporter: Impact on pemetrexed transport and on antifolates activities compared with the reduced folate carrier
Rongbao Zhao et al.
MOLECULAR PHARMACOLOGY (2008)
Organic anion transporter 3 (Oat3/Slc22a8) interacts with carboxyfluoroquinolones, and deletion increases systemic exposure to ciprofloxacin
Adam L. VanWert et al.
MOLECULAR PHARMACOLOGY (2008)
The effect of lopinavir/ritonavir on the renal clearance of tenofovir in HIV-infected patients
J. J. Kiser et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Multichannel liquid chromatography-tandem mass spectrometry cocktail method for comprehensive substrate characterization of multidrug resistance-associated protein 4 transporter
Yasuo Uchida et al.
PHARMACEUTICAL RESEARCH (2007)
Anti-inflammatory drugs and the kidney
A. A. House et al.
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS (2007)
Ciprofloxacin crystal nephropathy
Piero Stratta et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines
Constanze Hilgendorf et al.
DRUG METABOLISM AND DISPOSITION (2007)
Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H+-organic cation antiporters
Yuko Tanihara et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Effect of folate oversupplementation on folate uptake by human intestinal and renal epithelial cells
Balasubramaniem Ashokkumar et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2007)
Protection against cephalosporin-induced lipid peroxidation and nephrotoxicity by (+)-cyanidanol-3 and vitamin E
C. Cojocel et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2007)
Involvement of MRP4 (ABCC4) in the luminal efflux of ceftizoxime and cefazolin in the kidney
Lei Ci et al.
MOLECULAR PHARMACOLOGY (2007)
Ceftriaxone associated nephrolithiasis: a prospective study in 284 children
Masoumeh Mohkam et al.
PEDIATRIC NEPHROLOGY (2007)
Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2)
Yuichi Uwai et al.
PHARMACEUTICAL RESEARCH (2007)
Functional involvement of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir
Tomoki Imaoka et al.
MOLECULAR PHARMACOLOGY (2007)
Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex
S. Haenisch et al.
PHARMACOGENOMICS JOURNAL (2007)
Human renal organic anion transporter 4 operates as an asymmetric urate transporter
Yohannes Hagos et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2/ABCC2-and MRP4/ABCC4-mediated methotrexate transport
Azza A. K. El-Sheikh et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Characterization of CS-023 (RO4908463), a novel parenteral carbapenem antiobiotic, and meropenem as substrates of human renal transporter
Takahiro Shibayam et al.
DRUG METABOLISM AND PHARMACOKINETICS (2007)
Organic anion transporters of the SLC22 family: Biopharmaceutical, physiological, and pathological roles
Ahsan N. Rizwan et al.
PHARMACEUTICAL RESEARCH (2007)
Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy
Hassane Izzedine et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
The flounder organic anion transporter fOat has sequence, function, and substrate specificity similarity to both mammalian Oat1 and Oat3
Amy G. Aslamkhan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2006)
Renal parenchymal oxygenation and hypoxia adaptation in acute kidney injury
Christian Rosenberger et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2006)
Mechanism of active renal tubular efflux of tenofovir
Adrian S. Ray et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Ciprofloxacin crystal nephropathy - a 'new' cause of acute renal failure
Martin Sedlacek et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variants
Ilaria Badagnani et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Understanding and managing methotrexate nephrotoxicity
Brigitte C. Widemann et al.
ONCOLOGIST (2006)
Interactions of amoxicillin and cefaclor with human renal organic anion and peptide transporters
M Li et al.
DRUG METABOLISM AND DISPOSITION (2006)
Tenofovir-associated acute and chronic kidney disease: A case of multiple drug interactions
AE Zimmermann et al.
CLINICAL INFECTIOUS DISEASES (2006)
Pharmacokinetics and dosing recommendations of tenofovir disoproxil fumarate in hepatic or renal impairment
Brian P. Kearney et al.
CLINICAL PHARMACOKINETICS (2006)
Human organic anion transporter hOAT3 is a potent transporter of cephalosporin antibiotics, in comparison with hOAT1
H Ueo et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Tubulointerstitial diseases
GL Braden et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Organic anion transporter (Slc22a) family members as mediators of toxicity
DH Sweet
TOXICOLOGY AND APPLIED PHARMACOLOGY (2005)
Possible involvement of organic anion transporter 2 on the interaction of theophylline with erythromycin in the human liver
Y Kobayashi et al.
DRUG METABOLISM AND DISPOSITION (2005)
Antiviral drug-induced nephrotoxicity
H Izzedine et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
A mutation in the drug transporter gene ABCC2 associated with impaired methotrexate elimination
JS Hulot et al.
PHARMACOGENETICS AND GENOMICS (2005)
Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2) - Implications for altered drug disposition and central nervous system drug entry
W Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Function and regulation of multidrug resistance proteins (MRPs) in the renal elimination of organic anions
FM van de Water et al.
DRUG METABOLISM REVIEWS (2005)
Characterization of the cellular localization, expression level, and function of SNP variants of MRP2/ABCC2
M Hirouchi et al.
PHARMACEUTICAL RESEARCH (2004)
Fanconi's syndrome in HIV+ adults:: Report of three cases and literature review
KE Earle et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma
KR Crews et al.
CANCER (2004)
Quantitative evaluation of the drug-drug interactions between methotrexate and nonsteroidal anti-inflammatory drugs in the renal uptake process based on the contribution of organic anion transporters and reduced folate carrier
Y Nozaki et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney
T Mikkaichi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Tenofovir-related nephrotoxicity: Case report and review of the literature
CW James et al.
PHARMACOTHERAPY (2004)
Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules
S Ekaratanawong et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2004)
Organic anion transporting polypeptides of the OATP/SLC21 family:: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties
B Hagenbuch et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
Fanconi syndrome and acute renal failure in a patient treated with tenofovir:: a call for caution
G Gaspar et al.
AIDS (2004)
The use of methotrexate in rheumatoid arthritis
AT Borchers et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2004)
Efficacy and safety of tenofovir DF vs stavuldine in combination therapy in antiretroviral-naive patients - A 3-year randomized trial
JE Gallant et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Nephrolithiasis associated with ceftriaxone therapy: a prospective study in 51 children
Z Avci et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2004)
Tenofovir-related Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome:: The role of lopinavir-ritonavir-didanosine
F Rollot et al.
CLINICAL INFECTIOUS DISEASES (2003)
Tenofovir disoproxil fumarate
JE Gallant et al.
CLINICAL INFECTIOUS DISEASES (2003)
The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs
G Reid et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Identification of domains participating in the substrate specificity and subcellular localization of the multidrug resistance proteins MRP1 and MRP2
T Konno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Drug-induced renal failure: Update on new medications and unique mechanisms of nephrotoxicity
MA Perazella
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2003)
Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5
G Reid et al.
MOLECULAR PHARMACOLOGY (2003)
Interaction of human and rat organic anion transporter 2 with various cephalosporin antibiotics
S Khamdang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Human organic anion transporter 3 (hOAT3) can operate as an exchanger and mediate secretory urate flux
N Bakhiya et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2003)
Rapid communication: Acute renal failure associated with tenofovir: Evidence of drug-induced nephrotoxicity
S Coca et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2002)
Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs
S Khamdang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Expression of MRP4 confers resistance to ganciclovir and compromises bystander cell killing
M Adachi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Characterization of methotrexate transport and its drug interactions with human organic anion transporters
M Takeda et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors
A Enomoto et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Interaction of human organic anion transporters with various cephalosporin antibiotics
M Takeda et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Multiple interactions of cimetidine and probenecid with valaciclovir and its metabolite acyclovir
F De Bony et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Cidofovir-induced end-stage renal failure
P Meier et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
Human organic anion transporters and human organic cation transporters mediate renal antiviral transport
M Takeda et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Assessment of mitochondrial toxicity in human cells treated with tenofovir: Comparison with other nucleoside reverse transcriptase inhibitors
G Birkus et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Aristolochic acid impedes endocytosis and induces DNA adducts in proximal tubule cells
C Lebeau et al.
KIDNEY INTERNATIONAL (2001)
The safety and efficacy of adefovir dipivoxil in patients with advanced HIV disease: a randomized, placebo-controlled trial
EJ Fisher et al.
AIDS (2001)
Localization of the murine reduced folate carrier as assessed by immunohistochemical analysis
YH Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2001)
Na+-coupled transport of L-carnitine via high-affinity carnitine transporter OCTN2 and its subcellular localization in kidney
I Tamai et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2001)
Chronic aristolochic acid toxicity in rabbits: A model of Chinese herbs nephropathy?
JP Cosyns et al.
KIDNEY INTERNATIONAL (2001)
Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters
M Takeda et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Isolation of a family of organic anion transporters from human liver and kidney
W Sun et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney
SH Cha et al.
MOLECULAR PHARMACOLOGY (2001)
Direct toxicity of nonsteroidal antiinflammatory drugs for renal medullary cells
GM Rocha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Fluorescence-based assay for the interaction of small molecules with the human renal organic anion transporter 1
T Cihlar et al.
ANALYTICAL BIOCHEMISTRY (2000)
Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi).
JL Nortier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions
É Bakos et al.
MOLECULAR PHARMACOLOGY (2000)
β-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter
ME Ganapathy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
